Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
Vinicultural Investigation: A Survey of \Enjoying Fine Vintages\ Wine sampling- ‘This year nearly broke me as a scientist’ – US researchers reflect on how 2025’s science cuts have changed their lives
- Full SNAP benefits must be paid ‘promptly,’ USDA tells states as government reopens
- Grasping the Basics of Business Land Regulation
- The Job of Attorneys: It is Important to Comprehend When Legitimate Help
- Find the Effect of Web-based Entertainment on Society: Exploring the Computerized Scene
- A Gastronomic Experience in Healthy Enjoyments: A Survey of \Nutritious and Tasty\ Solid Cooking Recipe Book
- NASA astronauts take new moonsuit for a swim | Space photo of the day for Nov. 28, 2025
- New Year's superstitions: Eating 12 grapes, avoiding laundry and other rituals that are said to bring good fortune
